Open AccessPegylated IFN-α 2b added to ongoing lamivudine therapy in patients with lamivudine-resistant chronic hepatitis B
Author(s) -
Themistoklis Vassiliadis,
Kalliopi Patsiaoura,
Κωνσταντίνος Τζιόμαλος,
Theodoros Gkiourtzis,
Όλγα Γιουλεμέ,
Nikolaos Grammatikos,
Despoina Rizopoulou,
Nikolaos Nikolaidis,
Panagiotis Katsinelos,
Eleni Orfanou-Koumerkeridou,
Nikolaos Eugenidis
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i15.2417
Subject(s) - lamivudine , medicine , gastroenterology , pegylated interferon , alpha interferon , liver biopsy , hepatitis b , immunology , chronic hepatitis , biopsy , interferon , ribavirin , virus
To investigate the role of pegylated-interferon (IFN) alpha-2b in the management of patients with lamivudine-resistant chronic hepatitis B.